Pharmaceuticals
BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories, Countries and Regions
FRANKLIN LAKES, New Jersey, Aug. 7, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company,announced a voluntary recall onJune 23, 2020 for specified catalog numbers of the ChloraPrep™ 3 mL applicator due to possible fungal contamination, which only a...
2020-08-07 18:59
3691
Dietary cholesterol and phytosterols contribute directly to heart disease
Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk REYKJAVIK, Iceland, Aug. 7, 2020 /PRNewswire/ -- Scientists at deCODE genetics , a subsidiary of Amgen, and their collaborators fromthe Icelandic healthcare system, University of Iceland, the Copenha...
2020-08-07 01:21
5637
Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development
Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer gl...
2020-08-06 20:10
2820
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer
SHANGHAI and DUNDALK, Ireland, Aug. 6, 2020 /PRNewswire/ -- WuXi Vaccines, a global leading company with world-class vaccine contract development and manufacturing organization (CDMO) capabilities, is pleased to announce the appointment of Mr.Jian Dong as Chief Executive Officer (CEO). WuXi Vacci...
2020-08-06 17:00
3188
Colorcon Opens New Technical Centre in Melbourne, Australia to support the growing local pharmaceutical industry
HARLEYSVILLE, Penn., Aug. 5, 2020 /PRNewswire/ -- Colorcon, a world leader in the development and supply of film coating systems and excipients, today announces the opening of a new technical center inMelbourne, Australia. The facility provides customers in Australasia access to pharmaceutical cl...
2020-08-05 05:00
3462
TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis
Pretomanid, developed by the non-profit TB Alliance, has received EU marketing authorisation in combination regimen with bedaquiline and linezolid in adults with XDR-TB or treatment-intolerant/non-responsive MDR-TB PRETORIA, South Africa, Aug. 3, 2020 /PRNewswire/ -- Pretomanid, a novel compound...
2020-08-03 21:13
3018
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China
SUZHOU, China, Aug. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
2020-08-03 08:00
9042
Harbour BioMed Announces Strategic Partnership with Viva Biotech to Collaborate on Incubating Innovative Biotech Start-ups
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, SHANGHAI, China, July 31, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd. ("Viva Biotech"), a world-leading structure-based drug discovery platform today announced...
2020-07-31 08:56
5457
Ascletis' All-oral HCV Treatment Approved for Marketing in China
HANGZHOU and SHAOXING, China, July 31, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its all-oral HCV treatment has been approved for marketing inChina by National Medical Products Administration (NMPA). The Company's all-oral HCV treatment (RDV/DNV Regimen) is ...
2020-07-31 08:47
9951
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus
- INO-4800 showed durable antibody and T cell responses in rhesus macaques for 4 months - INO-4800 is the only vaccine to demonstrate long-term protection in non-human primates challenged with SARS-CoV-2 virus 13 weeks from vaccination - Memory T and B cell responses resulted in reduced viral l...
2020-07-30 20:34
6061
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that protects against subsequent infection First-in-human Phase 1/2a clinical trial now underway in United States and Belgium; Phase 3 clinical trial expected to commence in September NEW BR...
2020-07-30 17:55
10433
Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, trastuzumab biosimilar
SHANGHAI, July 30, 2020 /PRNewswire/ -- The European Commission (EC) has approved Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord)'s Zercepac®, a biosimilar trastuzumab, for the treatment of certain patients with HER2-positive early breast cancer, HER2-positive meta...
2020-07-30 08:00
5546
INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)
PLYMOUTH MEETING, Pennsylvania, July 29, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO) today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for INO-3107, its DNA medicine being evaluated in a Phase 1/2 trial for treatment of recurrent respiratory papillomat...
2020-07-29 19:30
4672
Atomo Diagnostics and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America
SYDNEY, July 29, 2020 /PRNewswire/ -- Atomo has announced that it has signed a binding agreement with US-based diagnostics specialist Access Bio Inc. (KOSDAQ: 950130) (Access Bio) that will see Atomo supply its unique, integrated rapid diagnostic test (RDT) devices to Access Bio for use with its ...
2020-07-29 08:47
2694
Oscotec to Use CDD Vault to Manage Its Chemistry and Biological Research Data
The company selected the platform to help streamline its drug discovery data management process SEONGNAM-SI, South Korea and BURLINGAME, California, July 29, 2020 /PRNewswire/ -- Oscotec, a Korean biotech company engaged in the clinical stage discovery of novel drug candidates for unmet needs, a...
2020-07-29 07:00
5136
Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited
BENGALURU, India, July 28, 2020 /PRNewswire/ -- Jubilant Biosys Limited ("Biosys"), a wholly owned subsidiary of Jubilant Life Sciences Limited, today announced completion of the merger with its sister company Jubilant Chemsys Limited, based in Noida,India. The combined entities will now operate ...
2020-07-28 20:27
4847
"White Mouse in Water" - Infinitus Develops New Technology of Using Zebrafish for Health Products Screening
GUANGZHOU, China, July 28, 2020 /PRNewswire/ -- Recently, the Chinese Institute of Food Science and Technology (CIFST) brought together experts inBeijing to evaluate the results of a collaborative R&D effort between Infinitus (China) Company Ltd. and Hangzhou Hunter Biotechnology Co., Ltd., named...
2020-07-28 20:00
4632
New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia
IRVINE, Calif. and HONG KONG, July 28, 2020 /PRNewswire/ -- IACTA Pharmaceuticals, Inc. ("IACTA" or the "Company") and Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited ("ZKO"), a leadingHong Kong-based pharmaceutical company, today announces they have entered into a definitive license agr...
2020-07-28 17:59
3732
AGC to Complete the Acquisition of MolMed on July 31, 2020
AGC Biologics adds leading-edge cell & gene therapy company in Milan, Italy SEATTLE, July 28, 2020 /PRNewswire/ -- AGC Biologics, a Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that they will acquire the majority of the share capital of Molec...
2020-07-28 10:00
3692
Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA
HANGZHOU, China, July 27, 2020 /PRNewswire/ -- Lynk Pharmaceuticals (Hangzhou, China) is pleased to announce exclusive licensing agreements with Kobe University (Kobe, Japan) and with RIKEN Research Institute (Saitama, Japan) to develop RAS inhibitors with a novel MOA. The agreement withKobe Univ...
2020-07-27 07:00
4079
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Transformation of Asia's Process Industries To Get A Boost Through Region's First Dedicated Process Technology Show
[Picked up by 279 media titles]
2024-11-12 16:00
Most Read
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5652
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
2024-11-11 21:00
5652
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5608
